Literature DB >> 25523599

Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes.

Mei-ling Xuan1, Chuan-jian Lu, Ling Han, Yu Xiang.   

Abstract

OBJECTIVE: To investigate whether the serum levels of inflammation-related cytokines might be different between the healthy individuals and the psoriatic patients diagnosed of three varied Chinese medicine (CM) syndromes [blood-stasis syndrome (BSS), blood-dryness syndrome (BDS) and wind-heat syndrome (WHS)].
METHODS: A total of 62 psoriatic patients were recruited and assigned to 3 groups according to their CM syndromes, including 27 patients of BSS, 21 of BDS and 14 of WHS. Another 20 sex- and age-matched healthy subjects were enrolled into the control group. Serum concentrations of multiple cytokines, including monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), soluble CD4O ligand (SCD40L), tumor necrosis factor-α (TNF-α), epidermal growth factor (EGF), interleukin-8 (IL-8), interleukin-17 (IL-17), interferon γ inducible protein-10 (IP-10) and vascular endothelial growth factor (VEGF), were measured by a multiplexed flow cytometric assay.
RESULTS: The circulating levels of MIP-1α, TNF-α, IL-8, and IP-10 were significantly increased in the psoriatic patients compared with the healthy controls (P<0.01). Male and female patients tended to have higher serum levels of MCP-1 and IP-10, respectively (P<0.05). Interestingly, compared with the control group, 6 out of the 9 cytokines (MCP-1, MIP-1α, TNF-α, EGF, IL-8 and IP-10) were substantially increased in the BSS group (P<0.05 or P<0.01), whereas only MIP-1α and IL-8 levels were elevated in the BDS group (P<0.05 or P<0.01) concurrent with lowered concentrations of SCD40L and IL-17 (P<0.05). In the WHS group, MIP-1α was the only cytokine whose level was evidently increased (P<0.01), in contrast to IL-17 which was decreased as compared with the control (P<0.05). The psoriatic patients overall owned higher levels of MIP-1α and IL-8 in the circulation which were comparable among the 3 groups of CM syndromes (P<0.01). In contrast, TNF-α level of the BSS group was the highest among the three (P<0.01), followed by the BDS and the WHS groups.
CONCLUSIONS: The expression profiles of cytokines in the circulation might not be necessarily identical for psoriatic patients with different CM syndromes. Accordingly, the serum concentrations of certain cytokines could potentially be used as the ancillary indices for the clinical classification of psoriatic CM syndromes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25523599     DOI: 10.1007/s11655-014-1792-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  17 in total

Review 1.  Psoriasis.

Authors:  Gayathri K Perera; Paola Di Meglio; Frank O Nestle
Journal:  Annu Rev Pathol       Date:  2011-11-04       Impact factor: 23.472

2.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

3.  Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array system.

Authors:  P Szodoray; P Alex; C M Chappell-Woodward; T M Madland; N Knowlton; I Dozmorov; M Zeher; J N Jarvis; B Nakken; J G Brun; M Centola
Journal:  Rheumatology (Oxford)       Date:  2006-08-27       Impact factor: 7.580

4.  Comparative study of systemic inflammatory responses in psoriasis vulgaris and mild to moderate allergic contact dermatitis.

Authors:  S Kaur; K Zilmer; V Leping; M Zilmer
Journal:  Dermatology       Date:  2012-08-09       Impact factor: 5.366

Review 5.  Psoriasis pathophysiology: current concepts of pathogenesis.

Authors:  J G Krueger; A Bowcock
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

6.  Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy.

Authors:  S Coimbra; H Oliveira; F Reis; L Belo; S Rocha; A Quintanilha; A Figueiredo; F Teixeira; E Castro; P Rocha-Pereira; A Santos-Silva
Journal:  Br J Dermatol       Date:  2010-11-08       Impact factor: 9.302

7.  A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis.

Authors:  L Wang; L Yang; L Gao; T W Gao; W Li; Y F Liu
Journal:  Int J Immunogenet       Date:  2007-12-18       Impact factor: 1.466

Review 8.  [The pathogenesis of inflammatory dermatoses, especially psoriasis].

Authors:  W E M Bos; H B Thio; H A M Neumann; L van der Fits; E P Prens
Journal:  Ned Tijdschr Geneeskd       Date:  2006-01-28

9.  Cardiovascular biomarkers in patients with psoriasis.

Authors:  Sascha Gerdes; Swetlana Osadtschy; Norbert Buhles; Hansjoerg Baurecht; Ulrich Mrowietz
Journal:  Exp Dermatol       Date:  2014-05       Impact factor: 3.960

10.  Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.

Authors:  Ozer Arican; Murat Aral; Sezai Sasmaz; Pinar Ciragil
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

View more
  4 in total

Review 1.  Effectiveness and safety of traditional Chinese medical bath therapy combined with ultraviolet irradiation in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Jingzhi Guan; Shaofei Yuan; Hanqimuge Wu; Risu Na; Xueqin Wu; Xin Wang; Shan Bao
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

2.  Interleukin-17A Gene Expression in Morbidly Obese Women.

Authors:  Fernando Zapata-Gonzalez; Teresa Auguet; Gemma Aragonès; Esther Guiu-Jurado; Alba Berlanga; Salomé Martinez; Andreu Martí; Fátima Sabench; Mercé Hernandez; Carmen Aguilar; Joan Josep Sirvent; Rosa Jorba; Daniel Del Castillo; Cristóbal Richart
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

3.  Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.

Authors:  Fan Bai; Wen Zheng; Yan Dong; Juan Wang; Malgorzata A Garstka; Ruilian Li; Jingang An; Huiqun Ma
Journal:  Oncotarget       Date:  2017-11-01

4.  'Psoriasis 1' reduces psoriasis‑like skin inflammation by inhibiting the VDR‑mediated nuclear NF‑κB and STAT signaling pathways.

Authors:  Wen Sun; Yang Gao; Xianhua Yu; Yuan Yuan; Jun Yi; Zhen Zhang; Yuxing Cheng; Yong Li; Xing Peng; Xushan Cha
Journal:  Mol Med Rep       Date:  2018-07-09       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.